DK1070713T3 - Quinoloncarboxylsyrederivater eller salte deraf - Google Patents

Quinoloncarboxylsyrederivater eller salte deraf

Info

Publication number
DK1070713T3
DK1070713T3 DK99912111T DK99912111T DK1070713T3 DK 1070713 T3 DK1070713 T3 DK 1070713T3 DK 99912111 T DK99912111 T DK 99912111T DK 99912111 T DK99912111 T DK 99912111T DK 1070713 T3 DK1070713 T3 DK 1070713T3
Authority
DK
Denmark
Prior art keywords
optionally substituted
alkoxy
amino
acid derivatives
substituted alkyl
Prior art date
Application number
DK99912111T
Other languages
Danish (da)
English (en)
Inventor
Tetsumi Yamakawa
Kazuya Hayashi
Tokunori Kito
Junichi Mitsuyama
Hiroshi Kuroda
Hiroyo Kawafuchi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK1070713T3 publication Critical patent/DK1070713T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99912111T 1998-04-06 1999-04-06 Quinoloncarboxylsyrederivater eller salte deraf DK1070713T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11014698 1998-04-06
JP34021798 1998-11-30

Publications (1)

Publication Number Publication Date
DK1070713T3 true DK1070713T3 (da) 2006-12-27

Family

ID=26449822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99912111T DK1070713T3 (da) 1998-04-06 1999-04-06 Quinoloncarboxylsyrederivater eller salte deraf

Country Status (15)

Country Link
US (1) US6335447B1 (fr)
EP (1) EP1070713B1 (fr)
JP (1) JP3346766B2 (fr)
KR (1) KR100550078B1 (fr)
CN (1) CN1152029C (fr)
AT (1) ATE342897T1 (fr)
BR (1) BRPI9909456B8 (fr)
CA (1) CA2327328C (fr)
CY (1) CY1105845T1 (fr)
DE (1) DE69933660T2 (fr)
DK (1) DK1070713T3 (fr)
ES (1) ES2273479T3 (fr)
HK (1) HK1039484A1 (fr)
PT (1) PT1070713E (fr)
WO (1) WO1999051588A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062805A1 (fr) * 2001-02-08 2002-08-15 Toyama Chemical Co., Ltd. Derive d'acide 6-substitue alkylamino-3-pyridylborique ou d'un sel de celui-ci et leurs procedes de fabrication
EP1698336A1 (fr) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Compositions antifongiques comprenant le sertaconazole ainsi que l' hydrocortisone ou un agent antibactérien
WO2007015453A1 (fr) * 2005-08-01 2007-02-08 Maruho Co., Ltd. Préparation sous forme de lotion contenant un dérivé d'acide pyridonecarboxylique
EP2177214A1 (fr) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Formes galéniques solides orales et utilisations
EP2177208A1 (fr) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Compositions pharmaceutiques topiques
EP2177209A1 (fr) 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Solutions intraveineuses et utilisations
MX2012011394A (es) 2010-04-06 2012-11-29 Ferrer Int Sales del acido 1-ciclopropil-8-metil-7-[5-metil-6-(metilamino)-3- piridinil]-4-oxo-1,4-dihidro-3-quinolincarboxilico.
TWI513688B (zh) * 2010-04-06 2015-12-21 Ferrer Int １－環丙基－８－甲基－７－〔５－甲基－６－（甲胺基）－３－吡啶基〕－４－側氧基－１，４－二氫－３－喹啉羧酸鹽
EP3034078A1 (fr) * 2010-09-27 2016-06-22 Emergent Product Development Gaithersburg Inc. Compositions antimicrobiennes à base de 2-pyridone
SG10201505811QA (en) 2011-08-31 2015-09-29 Otsuka Pharma Co Ltd Quinolone compound
EP3257512A4 (fr) * 2015-02-13 2018-07-25 Maruho Co., Ltd. Préparation externe comprenant un dérivé d'acide pyridonecarboxylique
JP2018528260A (ja) * 2015-07-28 2018-09-27 ビオーム バイオサイエンシズ プライベート リミティド 抗菌性治療薬及び予防薬
JP7347915B2 (ja) * 2016-04-28 2023-09-20 マルホ株式会社 抗菌剤
CA3042980A1 (fr) 2016-12-01 2018-06-07 Maruho Co., Ltd. Preparation medicale pour application externe sur la peau
CN107121506B (zh) * 2017-04-13 2019-06-07 杭州华东医药集团新药研究院有限公司 奥泽沙星杂质及其用途
CN108299480A (zh) * 2017-12-27 2018-07-20 山东百诺医药股份有限公司 一种奥泽沙星及其中间体的制备方法
WO2020065668A1 (fr) * 2018-09-26 2020-04-02 Maithri Drugs Pvt Ltd Forme cristalline de l'ozénoxacine et procédés de préparation associés
CN111675692A (zh) * 2020-06-08 2020-09-18 浙江科技学院 一种奥泽沙星的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3441788A1 (de) * 1984-11-15 1986-05-15 Bayer Ag, 5090 Leverkusen Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5075319A (en) 1987-09-08 1991-12-24 Sterling Drug Inc. Pyridinyl-quinolone compounds, their preparation and use
US4959363A (en) 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
JP3145487B2 (ja) 1992-06-12 2001-03-12 シスメックス株式会社 粒子分析装置
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JP3117721B2 (ja) * 1994-11-24 2000-12-18 エフ・ホフマン−ラ ロシュ アーゲー 新規なベンジルピリミジン類
CA2242242C (fr) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Derives de l'acide quinolonecarboxylique et leurs sels

Also Published As

Publication number Publication date
CN1299356A (zh) 2001-06-13
US6335447B1 (en) 2002-01-01
CY1105845T1 (el) 2011-02-02
EP1070713A1 (fr) 2001-01-24
BRPI9909456B1 (pt) 2013-10-29
CA2327328A1 (fr) 1999-10-14
PT1070713E (pt) 2006-12-29
DE69933660T2 (de) 2007-08-23
BRPI9909456A (pt) 2001-10-02
CN1152029C (zh) 2004-06-02
DE69933660D1 (de) 2006-11-30
KR20010042463A (ko) 2001-05-25
EP1070713B1 (fr) 2006-10-18
JP3346766B2 (ja) 2002-11-18
WO1999051588A1 (fr) 1999-10-14
ES2273479T3 (es) 2007-05-01
EP1070713A4 (fr) 2004-09-01
CA2327328C (fr) 2007-11-13
ATE342897T1 (de) 2006-11-15
KR100550078B1 (ko) 2006-02-08
HK1039484A1 (en) 2002-04-26
BRPI9909456B8 (pt) 2021-07-06

Similar Documents

Publication Publication Date Title
DK1070713T3 (da) Quinoloncarboxylsyrederivater eller salte deraf
NO20002169L (no) Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
IL72100A (en) 6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions comprising them
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
ATE282630T1 (de) Dolastatin-derivate
DE60112272D1 (de) Imidazopyridin-derivate
ZA971023B (en) Quinolonecarboxylic acid derivatives or their salts.
DK1262477T3 (da) Antibakterielle midler, der er virksomme mod syrefaste bakterier og indeholder pyridoncarboxylsyrer som aktiv ingrediens
MXPA04002649A (es) Diamidas insecticidas.
PL326024A1 (en) Novel derivatives of cyclodepsipeptidic substance pf1022
MXPA03004437A (es) Compuestos de deshalogeno.
DK1175429T3 (da) Halogenderivater af 9-deoxo-9a-aza-9a-homoerythromycin A
CA2211681A1 (fr) Nouveaux derives d'acide pyridonecarboxylique ou de ses sels et agent antibacterien contenant ces derives en tant qu'ingredient actif
KR930012768A (ko) 신규한 퀴놀린 카르복실산 유도체
GT199400033A (es) Compuestos antibacteriales (derivados de cefalosporina)